We turn research and knowledge into products and services that benefit society

The Innovation Award

Latest news

Latest news

Here you can read the latest news regarding Inven2s portfolio businesses, innovation projects and clinical studies. Every month we write longer articles where we interview current researchers and clinicians..

Events

Events

There are no upcoming events at this time.

Innovation

Inven2’s core business is innovation. We contribute in the process of commersialising good ideas from talented researchers, turning them into products and services that make a difference.

Clinical studies

Inven2 work closely with hospitals and companies to make sure clinical studies are completed quick and efficient, to the best for Norwegian patients.

Key figures 2010 – 2025

# Innovations (DOFI)

# Companies established

# Licence agreements

# New patent applications

MNOK transferred back to research, innovation and inventors

# Clinical Trials managed

Portfolio businesses

Portfolio businesses

Inven2 has a portfolio consisting of approximately 40 companies. These have been established either by us alone or together with investors and other partners. The point of departure for the companies are research results from innovative researchers. he portfolio value in December 2025 is NOK 4 billion, but this will vary with the value of the individual company and how long we are shareholders in the most valuable companies.

Products on the market

Products on the market

Inven2 has contributed to many products and services that have served society well through licensing to industry or business start-ups within a range of technology fields. What follows is a selection of them.